Astrazeneca PLC-Spons ADRAZN
13F holders, Q2 2026 (June 30)27holders −34
3new positions
37sold out
$189.33avg. 13F price*
At the end of Q2 2026, 27 institutions reported holding Astrazeneca PLC-Spons ADR (AZN) in their 13F filings, down 34 from Q1 2026. 3 opened new positions and 37 sold out. The largest holders were Mediolanum International Funds Ltd ($92.3M), Fayez Sarofim & Co ($34.1M) and Mengis Capital Management, Inc. ($8.9M).
- Company
- Astrazeneca PLC-Spons ADR
- CUSIP
- 046353108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $126.4M |
| Exits | 37 | $127.2M |
All 13F filers, Q1 2026 → Q2 2026: 676,231 shares bought and 697,560 shares sold, net −21,329 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Mediolanum International Funds Ltd | 0.79% | New | 487,420 | $92.3M |
| Fayez Sarofim & Co | 0.08% | New | 179,593 | $34.1M |
| Mengis Capital Management, Inc. | 1.35% | Add +0.1% | 46,736 | $8.9M |
| Wahed Invest LLC | 0.86% | Add +25.9% | 44,270 | $8.3M |
| Stanley-Laman Group, Ltd. | 0.45% | Reduce -1.9% | 23,593 | $4.5M |
| Westport Asset Management Inc. | 0.58% | No change | 7,500 | $1.4M |
| Raelipskie Partnership | 0.53% | No change | 7,412 | $1.4M |
| A. D. Beadell Investment Counsel, Inc. | 0.85% | No change | 6,975 | $1.3M |
| Harvest Fund Management Co., Ltd | 0.03% | No change | 5,158 | $978K |
| 1620 Investment Advisors, Inc. | 0.60% | Add +0.6% | 5,058 | $959K |
| Cullinan Associates Inc. | 0.06% | No change | 4,013 | $761K |
| Fruth Investment Management | 0.16% | No change | 3,499 | $663K |
| North Star Asset Management Inc. | 0.02% | No change | 2,656 | $504K |
| Philadelphia Trust Co. | 0.03% | No change | 2,498 | $474K |
| Curbstone Financial Management Corp | 0.07% | No change | 2,252 | $427K |
| South Shore Capital Advisors | 0.24% | No change | 1,939 | $363K |
| Keynote Financial Services LLC | 0.10% | No change | 1,134 | $215K |
| Asset Planning,Inc | 0.06% | No change | 500 | $95K |
| Pinnacle Holdings, LLC | 0.03% | No change | 400 | $76K |
| Ogorek Anthony Joseph /NY/ | 0.01% | No change | 208 | $39K |
| Byrne Asset Management LLC | 0.02% | No change | 147 | $28K |
| KERR FINANCIAL PLANNING Corp | 0.02% | No change | 110 | $21K |
| RMG Wealth Management LLC | 0.00% | Reduce -32.6% | 87 | $14K |
| Winch Advisory Services, LLC | 0.00% | No change | 21 | $4K |
| Strategic Wealth Advisors LLC | 0.00% | New | 35 | $3K |
| Lam Group, Inc. | 0.00% | No change | 1 | $190 |
| Huntington National Bank | 0.00% | No change | 1 | $93 |
"% of holder's portfolio" is AZN's weight in each manager's 13F, not the share of Astrazeneca PLC-Spons ADR the manager owns.